VEGF-A121a binding to Neuropilins–A concept revisited

26Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

All known splice isoforms of vascular endothelial growth factor A (VEGF-A) can bind to the receptor tyrosine kinases VEGFR-1 and VEGFR-2. We focus here on VEGF-A121a and VEGF-A165a, two of the most abundant VEGF-A splice isoforms in human tissue1, and their ability to bind the Neuropilin co-receptors NRP1 and NRP2. The Neuropilins are key vascular, immune, and nervous system receptors on endothelial cells, neuronal axons, and regulatory T cells respectively. They serve as co-receptors for the Plexins in Semaphorin binding on neuronal and vascular endothelial cells, and for the VEGFRs in VEGF binding on vascular and lymphatic endothelial cells, and thus regulate the initiation and coordination of cell signaling by Semaphorins and VEGFs.2 There is conflicting evidence in the literature as to whether only heparin-binding VEGF-A isoforms–that is, isoforms with domains encoded by exons 6 and/or 7 plus 8a–bind to Neuropilins on endothelial cells. While it is clear that VEGF-A165a binds to both NRP1 and NRP2, published studies do not all agree on the ability of VEGF-A121a to bind NRPs. Here, we review and attempt to reconcile evidence for and against VEGF-A121a binding to Neuropilins. This evidence suggests that, in vitro, VEGF-A121a can bind to both NRP1 and NRP2 via domains encoded by exons 5 and 8a; in the case of NRP1, VEGF-A121a binds with lower affinity than VEGF-A165a. In in vitro cell culture experiments, both NRP1 and NRP2 can enhance VEGF-A121a-induced phosphorylation of VEGFR2 and downstream signaling including proliferation. However, unlike VEGFA-165a, experiments have shown that VEGF-A121a does not ‘bridge’ VEGFR2 and NRP1, i.e. it does not bind both receptors simultaneously at their extracellular domain. Thus, the mechanism by which Neuropilins potentiate VEGF-A121a-mediated VEGFR2 signaling may be different from that for VEGF-A165a. We suggest such an alternate mechanism: interactions between NRP1 and VEGFR2 transmembrane (TM) and intracellular (IC) domains.

References Powered by Scopus

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor

2171Citations
N/AReaders
Get full text

Heparan sulphate proteoglycans fine-tune mammalian physiology

1373Citations
N/AReaders
Get full text

The GxxxG motif: A framework for transmembrane helix-helix association

816Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Biology and therapeutic targeting of vascular endothelial growth factor A

151Citations
N/AReaders
Get full text

VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment

109Citations
N/AReaders
Get full text

Neuropilins in the context of tumor vasculature

70Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sarabipour, S., & Mac Gabhann, F. (2018, May 4). VEGF-A121a binding to Neuropilins–A concept revisited. Cell Adhesion and Migration. Taylor and Francis Inc. https://doi.org/10.1080/19336918.2017.1372878

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

84%

Researcher 3

16%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

33%

Biochemistry, Genetics and Molecular Bi... 6

33%

Agricultural and Biological Sciences 4

22%

Pharmacology, Toxicology and Pharmaceut... 2

11%

Save time finding and organizing research with Mendeley

Sign up for free